Results 181 to 190 of about 17,841 (204)

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy [PDF]

, 2019
Azab, Abdel Kareem, Azab, Feda, Fiala, Mark, Fogler, William E., King, Justin, Kohnen, Daniel, Magnani, John L., Muz, Barbara, Smith, Ted, Vij, Ravi   +9 more
core   +1 more source

ST3 beta-galactoside alpha-2,3-sialyltransferase 4 (St3gal4) deficiency reveals correlations among alkaline phosphatase activity, metabolic parameters, and fear-related behavior in mice. [PDF]

Metab Brain Dis
Tangsudjai S, Fujita A, Tamura T, Okuno T, Oda M, Kato K.   +5 more
europepmc   +1 more source

Biological evaluation of sulfonate and sulfate analogues of lithocholic acid: A bioisosterism-guided approach towards the discovery of potential sialyltransferase inhibitors for antimetastatic study

Ser John Lynon P. Perez, Chia-Ling Chen, Tzu‐Ting Chang, Wen‐Shan Li   +3 more
openalex   +1 more source

Molecular cloning and expression of a human hST8Sia VI (α2,8-sialyltransferase) responsible for the synthesis of the diSia motif on O-glycosylproteins

, 2005
Mélanie Teintenier-Lelièvre, Sylvain Julien, Sylvie Juliant, Yann Guérardel, Martine Duonor-Cérutti, Philippe Delannoy, Anne Harduin‐Lepers   +6 more
openalex   +1 more source

Genetic insights into blood protein correlations with colorectal cancer: a Mendelian randomization study. [PDF]

Discov Oncol
Xu W, Li W, Li Y, Kuai D, Sun W, Liu X, Xu B.   +6 more
europepmc   +1 more source

Glycoengineering with neuraminic acid analogs to label lipooligosaccharides and detect native sialyltransferase activity in gram-negative bacteria. [PDF]

Glycobiology
Alvarado-Melendez EI, de Jong H, Hartman JEM, Ong JY, Wösten MMSM, Wennekes T.   +5 more
europepmc   +1 more source

Differential expression of ST6GALNAC1 and ST6GALNAC2 and their clinical relevance to colorectal cancer progression. [PDF]

PLoS One
Ahmad MS, Braoudaki M, Siddiqui SS.
europepmc   +1 more source

Fate of Mammalian Golgi Sialyltransferases in Yeast [PDF]

, 2002
Sievi, Eeva
core  

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells. [PDF]

Cancers (Basel)
Goode EA, Orozco-Moreno M, Hodgson K, Nabilah A, Murali M, Peng Z, Merx J, Rossing E, Pijnenborg JFA, Boltje TJ, Wang N, Elliott DJ, Munkley J.   +12 more
europepmc   +1 more source